The largest database of trusted experimental protocols

202 il cf

Manufactured by R&D Systems

202-IL/CF is a laboratory instrument designed for the analysis and detection of interleukin (IL) and other cytokine-related factors (CF) in biological samples. The core function of this product is to provide researchers with a reliable and efficient tool for conducting immunoassays and quantifying the levels of specific proteins in their experiments.

Automatically generated - may contain errors

2 protocols using 202 il cf

1

Quantifying NK Cell Proliferation and Cytotoxicity under TGFβ1 Influence

Check if the same lab product or an alternative is used in the 5 most similar protocols
NK cell proliferation and inhibition in the presence of TGFβ1 was determined as previously described.33 (link) Enriched NK cells from human PBMC (Human NK Cell Enrichment Kit, STEMCELL Technologies, 19055) were used. NK cells were activated by recombinant human IL-2 (10 IU/mL; R&D Systems, 202-IL/CF) for 3 days in the presence or absence of various concentrations of TGFβ1 (R&D systems). NK cell proliferation was observed by staining with Ki-67-BUV395 antibody (BD Bioscience, 564071) using flow cytometry. TGFβ1 was added at the time of setup with or without SAR439459 or isotype control (IgG4) for 3 days. NK cytotoxicity assays were performed using K562 cells (ATCC® CCL-243™) as targets. NK and K562 cells were cocultured (effector-to-target ratio 5:1) in RPMI-1640 media (GIBCO, 11835–030) supplemented with 10% FBS (GIBCO, 10082–147), and delivery of granzyme B was quantitated by intracellular FACS analysis using GranToxiLux™ assay kit as described (OncoImmunin, Inc, GTL702-8), for 2 hours. In some experiments, culture supernatants were collected for cytokine, GZB, perforin analysis by MSD (Meso Scale Diagnostics) or Luminex (ThermoFisher Scientific).
+ Open protocol
+ Expand
2

Naïve CD4+ T Cell Activation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Purified naïve CD4+ T cells (5 × 105) were cultured in 1 ml of complete medium containing human IL-2 (2 ng/ml, 202-IL/CF, R&D Systems) in 48-well plates and stimulated with plate-bound anti-CD3 (2 μg/ml, 555329, BD Pharmingen) and soluble anti-CD28 monoclonal antibodies (2 μg/ml, 555726, BD Pharmingen) for 5 d. The exogenous cytokines used were IL-1β (20 ng/ml), IL-6 (100 ng/ml), IL-23 (100 ng/ml), and TNF-α (50 ng/ml). Recombinant human IL-1β, IL-6, and TNF-α were purchased from Peprotech.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!